Back to mobile site

More on SPTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.9 Score)

Upcoming Events

- Earnings (Posted Today)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:SPTX)
Delayed: 20.01 +0.41 (2.09%)
Prev. Close $19.60  
Open$19.68 
52 Wk High$ 
52 Wk Low$ 
Day High$21.07 
Day Low$19.13 
P/E N/A  
EPS$ 
Volume527,902 

Friends, Peers and Foes (?): PRTC (more...)

Nov 2, 2026 07:11 AM Seaport Therapeutics, Inc. (SPTX) Misses Q3 EPS by 49c
Nov 2, 2026 07:09 AM Form 10-Q Seaport Therapeutics, For: Sep 30
Nov 2, 2026 07:04 AM Form 8-K Seaport Therapeutics, For: Nov 02
Nov 2, 2026 07:00 AM Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Oct 28, 2026 07:00 AM Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference
Oct 14, 2026 05:14 AM Canaccord Starts Seaport Therapeutics (SPTX) at Buy
Oct 9, 2026 01:00 PM Seaport Therapeutics shares Phase 1 PK data for GlyphAgo at ECNP
Oct 9, 2026 01:00 PM PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
Oct 9, 2026 07:00 AM Seaport Therapeutics shares Phase 1 PK data for GlyphAgo at ECNP
Oct 9, 2026 07:00 AM Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
View All Articles

Entities mentioned with SPTX

View All Entities